Ozempic menu: Could restaurants be normalizing a weight loss drug?
GLP-1 drugs like Ozempic suppress appetite and cravings, driving rapid global uptake and creating potential disruptions for the food and hospitality industries.
Weight loss drugs can halve heart patients' risk of early death, study finds
GLP-1 agonist weight-loss drugs substantially reduce hospitalization and premature death risk in obese heart failure patients with type 2 diabetes, up to 58%.
Novo Nordisk, creator of the mega-hit drug Ozempic, has seen a loss of nearly $100 billion in market value due to collapsing sales and missed forecasts.
Doctors Are Warning That Ozempic's Severe Side Effects May Outweigh Its Benefits
GLP-1 weight loss drugs like Ozempic and Wegovy have concerning side effects, including potential vision impairment and increased risk of kidney problems.
Obesity drugs show promise treating a new ailment: migraine
In a small study, the drug liraglutide reduced monthly migraine episodes by nearly half among people with obesity who experience the headache-inducing condition.
